Ginko Bioworks and Cronos partner to facilitate the future production of lab-grown cannabis.
Terpenes are the relatively unresearched molecules present in cannabis products. Unlocking their potential could provide a whole new array of cannabis uses and benefits.
Novel drug delivery system developed by researchers at CBIS offers a potential fix for those suffering from long-term, acute pain.
With the legalization of cannabis use in Canada looming, concerns are increasing over the risks associated with admitting association with the drug when crossing U.S. border.
A new system is being introduced to allow black and gray market cannabis producers to introduce and protect their unique cannabis strains in the Canadian cannabis market.
The authors behind the work believe that CBD may constitute an excellent candidate for the treatment of MS and other autoimmune diseases as a novel, non-psychoactive therapeutic.
This article highlights the areas where Illinois could make improvements in order to establish a more efficient and effective medicinal cannabis treatment program.
Self-reporting study fuels debate over the potential risks to mental health of long term, high THC concentrate use.
A clinical trial involving 20 Canadian children with severe intractable epilepsy has posted resulting indicating cannabis oil could reduce seizures by over 70%.